Retraction: Drug-Eluting Stents for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.

Retraction: Drug-Eluting Stents for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.

Bibliographic Details
Main Author:	PLOS ONE Editors
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4961278?pdf=render

Similar Items

Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
by: Lulu Liu, et al.
Published: (2018-03-01)

Efficacy and safety of polymer-free stent versus polymer-permanent drug-eluting stent in patients with acute coronary syndrome: a meta-analysis of randomized control trials
by: Kang Gao, et al.
Published: (2017-07-01)

Effect of pioglitazone on in-stent restenosis after coronary drug-eluting stent implantation: a meta-analysis of randomized controlled trials.
by: Ming-duo Zhang, et al.
Published: (2014-01-01)

Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: a meta-analysis
by: Tingting Wei, et al.
Published: (2022-06-01)

Drug-eluting balloon versus bare-mental stent and drug-eluting stent for de novo coronary artery disease: A systematic review and meta-analysis of 14 randomized controlled trials.
by: Kongyong Cui, et al.
Published: (2017-01-01)

Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis
by: Frederic C. Daoud, et al.
Published: (2022-12-01)

Five-Year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome: A Meta-Analysis
by: Frederic C. Daoud, et al.
Published: (2023-11-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials.
by: Benedetto, U, et al.
Published: (2016)

Optimal duration of DAPT after second-generation drug-eluting stent in acute coronary syndrome.
by: Ji-Yong Jang, et al.
Published: (2018-01-01)

Endovascular Treatment with Limus Eluting Stents in Patients with Acute Coronary Syndrome
by: M. V. Chernyayev, et al.
Published: (2019-04-01)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
by: Yong Zhu, et al.
Published: (2021-12-01)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
by: Yong Zhu, et al.
Published: (2021-07-01)

Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
by: PLOS ONE Editors
Published: (2024-01-01)

Duration of dual antiplatelet therapy in patients with acute coronary syndrome undergoing drug-eluting stent implantation: A meta-analysis
by: Xue Geng, et al.
Published: (2020-04-01)

First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry)
by: Damian Kawecki, et al.
Published: (2016-01-01)

Drug deposition in coronary arteries with overlapping drug-eluting stents
by: Olgac, Ufuk, et al.
Published: (2017)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
by: Mohammad Saifur Rohman, et al.
Published: (2023-07-01)

Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
by: Le Ni, et al.
Published: (2020-01-01)

Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials
by: Ping Zhu, et al.
Published: (2018-08-01)

Retraction: Comparison of acupuncture and other drugs for chronic constipation: A network meta-analysis.
by: PLOS ONE Editors
Published: (2018-01-01)

Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010-09-01)

Retraction: A parallel randomized controlled trial examining the effects of rhythmic sensory stimulation on fibromyalgia symptoms.
by: PLOS ONE Editors
Published: (2020-01-01)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
by: Alaide Chieffo, et al.
Published: (2007-09-01)

Incidence of coronary drug-eluting stent fracture: A systematic review and meta-analysis
by: Yang Chen, et al.
Published: (2022-08-01)

Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
by: Xiao Long Lin, et al.
Published: (2022-09-01)

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis
by: Hiroshi Fujita, et al.
Published: (2014-12-01)

Use of drug-eluting versus bare-metal stents after an acute coronary syndrome in Portugal: The EURHOBOP study
by: Vítor Barros, et al.
Published: (2015-07-01)

Efficacy and Safety of Very Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Peng-Yu Zhong, et al.
Published: (2021-09-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
by: E. Y. Zagorulko, et al.
Published: (2019-01-01)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
by: Imad Sheiban, et al.
Published: (2008-02-01)

Drug-eluting coronary stents in clinical practice: lessons from the «BAsel Stent Kosten-Effektivitäts Trials» (BASKET)
by: Swiss Medical Weekly
Published: (2011-08-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Open-labeled randomized controlled trial to evaluate the 1-year clinical outcomes of polymer-free sirolimus-eluting coronary stents as compared with biodegradable polymer-based sirolimus-eluting coronary stents
by: Sunitha Viswanathan, et al.
Published: (2018-12-01)

XLIMus drug eluting stent: A randomIzed controlled Trial to assess endothelialization. The XLIMIT trial
by: Luca Testa, et al.
Published: (2019-06-01)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
by: Juntao Yin, et al.
Published: (2023-01-01)

Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Endrin Koni, et al.
Published: (2021-03-01)

Drug-coated balloons versus drug-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention: an updated meta-analysis with trial sequential analysis
by: Ahmed Abdelaziz, et al.
Published: (2023-12-01)

Drug-eluting stents for coronary artery disease in the perspective of bibliometric analysis
by: Ying Zeng, et al.
Published: (2024-02-01)

Triple-vessel coronary artery aneurysms following drug-eluting stents
by: Immaneni Sathyamurthy, et al.
Published: (2023-01-01)